Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Use of Glucose and Saline for Fetal Movement Perception

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
Information provided by:
Tel-Aviv Sourasky Medical Center Identifier:
First received: December 14, 2010
Last updated: March 3, 2011
Last verified: March 2011
The purpose of this study is to investigate the hypothesis that glucose administration increases fetal movement perception by the pregnant woman.

Condition Intervention
Fetal Movement Perception
Drug: IV glucose 5%
Drug: saline

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Impact of Glucose Administration on Perception of Fetal Movements

Resource links provided by NLM:

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Primary Outcome Measures:
  • fetal movements as perceived by the mother [ Time Frame: one hour ]
    Effect of glucose versus saline infusion on the perception of fetal movements. the mother will count fetal movements that she feels one hour following saline/glucose infusion and report to the obstetrician in charge. The research aims to clarify whether glucose increases fetal movements.

Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Study Completion Date: January 2012
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: glucose 5%
glucose 5%
Drug: IV glucose 5%
500 ml glucose 5% within 30 minutes
Active Comparator: saline
Drug: saline


Ages Eligible for Study:   18 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Healthy parturients with singleton pregnancy during 3rd trimester

Exclusion Criteria:

  • Any maternal medical condition (Diabetes, hypertension), multiple pregnancy, fetal anomaly, polyhydramnios
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01308359

Contact: Ariel Many, MD 97236925633
Contact: NAdav Mishan, MD 97236925633

Lis Maternity Hospital, Tel Aviv Sourasky Medical Center Recruiting
Tel Aviv, Israel, 64239
Contact: Ariel Many, MD    97236925633      
Contact: Nadav Mishan, MD    97236925633      
Principal Investigator: Ariel Many, MD         
Sub-Investigator: Nadav Mishan, MD         
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Principal Investigator: Ariel Many, MD Lis Maternity Hospital
  More Information

Responsible Party: Ariel Many, MD, Dep. of OB&GYN, Tel Aviv Sourasky Medical Center Identifier: NCT01308359     History of Changes
Other Study ID Numbers: TASMC-10-am-0512-CTIL
Study First Received: December 14, 2010
Last Updated: March 3, 2011

Keywords provided by Tel-Aviv Sourasky Medical Center:
fetal movement processed this record on May 25, 2017